Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for National Research (NRC) over the last 16 years, with Q3 2025 value amounting to $49000.0.

  • National Research's Gains from Investment Securities rose 11304.35% to $49000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 2342.18%. This contributed to the annual value of $8.2 million for FY2024, which is 791.54% down from last year.
  • Latest data reveals that National Research reported Gains from Investment Securities of $49000.0 as of Q3 2025, which was up 11304.35% from $51000.0 recorded in Q2 2025.
  • In the past 5 years, National Research's Gains from Investment Securities ranged from a high of $5.7 million in Q2 2022 and a low of $23000.0 during Q3 2024
  • Its 5-year average for Gains from Investment Securities is $1.9 million, with a median of $2.1 million in 2023.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first surged by 210928.96% in 2021, then tumbled by 9898.45% in 2024.
  • National Research's Gains from Investment Securities (Quarter) stood at $4.0 million in 2021, then dropped by 18.72% to $3.3 million in 2022, then dropped by 25.5% to $2.4 million in 2023, then decreased by 20.14% to $2.0 million in 2024, then crashed by 97.49% to $49000.0 in 2025.
  • Its Gains from Investment Securities was $49000.0 in Q3 2025, compared to $51000.0 in Q2 2025 and $80000.0 in Q1 2025.